The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy

• Status: Terminated
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Preliminary studies have shown a benefit of sodium bicarbonate infusion in decreasing the risk of contrast induced nephropathy with coronary angiography. The investigators plan to randomize 478 patients (with serum creatinine 1.5 mg/dl or greater) undergoing coronary angiography to intravenous isotonic saline or intravenous isotonic sodium bicarbonate beginning one hour before the procedure and for four hours after. The primary endpoint is the development of contrast nephropathy within 48-72 hours after the procedure. Patients with an ejection fraction <30%, overt CHF, hypokalemia and alkalemia will be excluded.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lenox Hill Hospital
• Collaborator: GE Healthcare

Criteria

Inclusion Criteria:

• serum creatinine greater then or equal to 1.5

Exclusion Criteria:

• EF<30

• Overt CHF

• Alkalemia

• Hypokalemia

• GFR<20 cc/min